Zurcher Kantonalbank Zurich Cantonalbank Purchases 1,277 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 23.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 6,621 shares of the medical instruments supplier’s stock after buying an additional 1,277 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in ICU Medical were worth $1,027,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. Arizona State Retirement System increased its position in ICU Medical by 1.0% during the 4th quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier’s stock worth $1,044,000 after buying an additional 65 shares during the period. Equitable Trust Co. increased its position in ICU Medical by 1.6% during the fourth quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier’s stock worth $822,000 after acquiring an additional 84 shares during the period. Gagnon Securities LLC raised its stake in ICU Medical by 0.5% in the 4th quarter. Gagnon Securities LLC now owns 28,881 shares of the medical instruments supplier’s stock worth $4,481,000 after purchasing an additional 137 shares in the last quarter. Wealthspire Advisors LLC boosted its holdings in ICU Medical by 6.4% in the 4th quarter. Wealthspire Advisors LLC now owns 2,660 shares of the medical instruments supplier’s stock valued at $413,000 after purchasing an additional 160 shares during the period. Finally, State of New Jersey Common Pension Fund D grew its position in shares of ICU Medical by 1.6% during the 4th quarter. State of New Jersey Common Pension Fund D now owns 12,370 shares of the medical instruments supplier’s stock worth $1,919,000 after purchasing an additional 191 shares in the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on ICUI shares. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Tuesday. Raymond James set a $97.00 target price on ICU Medical in a report on Wednesday, March 12th. Finally, Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a research note on Wednesday, December 11th. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $168.67.

ICU Medical Trading Up 2.1 %

Shares of ICUI stock opened at $151.25 on Thursday. ICU Medical, Inc. has a fifty-two week low of $93.36 and a fifty-two week high of $196.26. The stock’s fifty day moving average price is $156.48 and its two-hundred day moving average price is $164.65. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The company has a market cap of $3.71 billion, a PE ratio of -33.10 and a beta of 0.73.

Insider Activity at ICU Medical

In related news, CEO Vivek Jain sold 1,373 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the transaction, the chief executive officer now owns 104,593 shares of the company’s stock, valued at $16,262,119.64. This represents a 1.30 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 6.70% of the stock is currently owned by insiders.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.